Back to Results
First PageMeta Content



A Phase I/II Study of GMI-1271, a Novel E-selectin Antagonist, in Combination with Induction Chemotherapy in Relapsed/Refractory and Previously Untreated Elderly Patients with Acute Myeloid Leukemia; Results to Date Dan
Add to Reading List

Document Date: 2016-12-05 13:18:26


Open Document

File Size: 1,05 MB

Share Result on Facebook
UPDATE